Sarepta Therapeutics, Inc 10-Q for FY2026 Q3
Sarepta Therapeutics, Inc. (SRPT)
10-Q
2026-11-05
For: 2026-09-30
View Original
Added on
November 05, 2026
About this 10-Q
Sarepta Therapeutics, Inc filed this 10-Q on November 5, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).
Sarepta Therapeutics reported nine-month net income of $297,608 thousand versus a $301,184 thousand loss, while collaboration and other revenue reached $530,438 thousand. AI summary
Headline figures
Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $381.35M
- down 4.5% from $399.36M a year earlier
- Net loss
- $28.46M
- compared with a net loss of $50.57M a year earlier
- Diluted EPS
- -$0.27
- compared with -$0.50 a year earlier